<DOC>
	<DOCNO>NCT02561520</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy autologous Platelet Rich Plasma ( PRP ) Platelet Poor Plasma ( PPP ) eye drop four time day treatment ocular graft versus host disease ( O-GVHD ) . In addition current medication ( except autologous serum drop ) , patient receive PRP PPP drop .</brief_summary>
	<brief_title>Safety Efficacy Autologous PRP PPP Eye Drops Treatment Ocular GVHD</brief_title>
	<detailed_description>Ocular involvement quite symptomatic patient chronic graft-versus-host disease ( GVHD ) . The impact ocular GVHD quality life ( QOL ) patient chronic GVHD study prospective , multicenter , longitudinal , observational study show ocular GVHD affect 57 % patient within 2 year chronic GVHD diagnosis . Strong evidence suggest ocular GVHD associate bad overall health-related QOL . Significant worsen vision-related QOL ocular GVHD report . Ocular GVHD devastate effective treatment available far . The importance study first time nation , institute evaluate safety efficacy topical autologous blood product ( PRP PPP ) treat ocular surface disease associate ocular GVHD .</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Age â‰¥18 year . Willing able provide write informed consent . Willing able comply study assessment full duration study . Diagnosis ocular GVHD . Minimum corneal fluorescein stain 4 ( NEI grade scheme , 015 ) least one eye . In good stable overall health . Remission primary cancer 5 year . History thrombocytopenia ( platelet &lt; 50,000 ) last 2 week study entry . Ocular periocular malignancy . Significant change , judge PI , systemic immunosuppressive regimen 2 week study entry . Any change dosage tetracycline compound ( tetracycline , doxycycline , minocycline ) within last month . Any change frequency preserve antiglaucoma medication 2 week study entry . Current use topical steroid twice day . Change frequency topical cyclosporine and/or topical kineret within last month . Signs current infection , include fever current treatment antibiotic . Intraocular surgery ocular laser surgery within last 3 month . Has wear contact lens , except bandage contact lens rigid gas permeable lens scleral contact lens , last 2 week prior study would unable stay contact lens study duration . Any condition ( include language barrier ) preclude patient 's ability comply study requirement include completion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>platelet rich plasma</keyword>
	<keyword>platelet poor plasma</keyword>
	<keyword>ocular GVHD</keyword>
</DOC>